Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001483813-12-000028)

Filing Details

Accession Number:: 0001483813-12-000028
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-08-28 18:22:25
Reporting Period:: 2012-08-27

Filing Date:: 2012-08-28
Accepted Time:: 2012-08-28 18:22:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1159036	Halozyme Therapeutics Inc	HALO	Biological Products, (No Disgnostic Substances) (2836)	880488686

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1291219	J Kenneth Kelley	C/O Halozyme Therapeutics, Inc. 11388 Sorrento Valley Road San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-08-27	20,000	$5.70	150,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This transaction was executed in multiple purchases through a purchase order executed by a broker-dealer at prices ranging from $5.66 to $5.71. The price reported in this column reflects the weighted average purchase price. The Reporting Person will provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares purchased at each separate price.